Funding for this research was provided by:
National Natural Science Foundation of China (81873999, 81672158)
National key research and development program of China (2016YFC1100100)
Received: 12 August 2020
Accepted: 31 January 2021
First Online: 18 February 2021
Ethics approval and consent to participate
: All patients agreed and signed to participate on this clinical trial. All procedures performed in this study involving human participants were in accordance with the bioethical standards of the institutional and the national research committee (Ethics Committee of the Union Hospital, Tongji Medical College, Huazhong University of Science and Technology) and with the 1964 Helsinki declaration and its later amendments.
: Not applicable.
: The authors declare that they have no competing interests.